Stock listing
NASDAQ:COYA Coya Therapeutics, Inc. Stock
Home listing (NASDAQ) of Coya Therapeutics, Inc.
Follow Coya Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:COYA
$3.11 USD -0.12 (-3.7%)
Close on Nov 3, 2026
- Day range
- $3.03 – $3.41 USDNov 3, 2026
- Volume
- 518,217 sharesNov 3, 2026
- Market cap
- $72.95M USDAt the close on Nov 3, 2026 · price × 23.46M shares outstanding
- 52-week range
- $3.03 – $6.62 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $625,755 USDMedian day 116,543 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:COYA · Home | $3.11 USD | -0.12 (-3.7%) | 518,217 | $3.26 | $3.405 | $3.03 | $3.23 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:COYA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.11 | -0.12 | -3.7% | $3.26 | $3.405 | $3.03 | 518,217 | |
| $3.23 | -0.38 | -10.5% | $3.64 | $3.89 | $3.175 | 270,174 | |
| $3.61 | -0.37 | -9.3% | $3.96 | $4.085 | $3.594 | 214,740 | |
| $3.98 | -0.08 | -2.0% | $4.08 | $4.20 | $3.95 | 70,105 | |
| $4.06 | -0.06 | -1.5% | $4.09 | $4.175 | $4.045 | 150,844 | |
| $4.12 | +0.17 | +4.3% | $3.97 | $4.30 | $3.94 | 55,827 | |
| $3.95 | +0.01 | +0.3% | $3.95 | $4.03 | $3.91 | 129,572 | |
| $3.94 | -0.20 | -4.8% | $4.08 | $4.245 | $3.935 | 188,644 | |
| $4.14 | 0.00 | 0.0% | $4.09 | $4.43 | $4.09 | 82,988 | |
| $4.14 | -0.07 | -1.7% | $4.23 | $4.29 | $4.10 | 95,099 | |
| $4.21 | +0.01 | +0.2% | $4.22 | $4.38 | $4.21 | 82,913 | |
| $4.20 | -0.05 | -1.2% | $4.29 | $4.535 | $4.20 | 106,480 | |
| $4.25 | -0.09 | -2.1% | $4.37 | $4.39 | $4.16 | 134,191 | |
| $4.34 | +0.16 | +3.8% | $4.18 | $4.50 | $4.14 | 236,556 | |
| $4.18 | -0.295 | -6.6% | $4.645 | $4.645 | $4.16 | 258,003 | |
| $4.475 | -0.335 | -7.0% | $4.81 | $4.89 | $4.45 | 207,772 | |
| $4.81 | -0.14 | -2.8% | $5.00 | $5.05 | $4.81 | 102,055 | |
| $4.95 | -0.04 | -0.8% | $5.00 | $5.05 | $4.85 | 151,829 | |
| $4.99 | +0.08 | +1.6% | $4.91 | $5.00 | $4.70 | 144,420 | |
| $4.91 | +0.06 | +1.2% | $4.81 | $5.01 | $4.755 | 95,511 | |
| $4.85 | 0.00 | 0.0% | $4.86 | $5.03 | $4.74 | 94,629 | |
| $4.85 | +0.04 | +0.8% | $4.85 | $4.94 | $4.78 | 117,247 | |
| $4.81 | +0.08 | +1.7% | $4.80 | $4.93 | $4.76 | 88,690 | |
| $4.73 | -0.28 | -5.6% | $5.00 | $5.00 | $4.70 | 116,132 | |
| $5.01 | -0.02 | -0.4% | $5.06 | $5.15 | $4.98 | 101,360 | |
| $5.03 | +0.05 | +1.0% | $5.02 | $5.05 | $4.93 | 75,465 | |
| $4.98 | -0.10 | -2.0% | $5.03 | $5.12 | $4.96 | 120,318 | |
| $5.08 | -0.10 | -1.9% | $5.19 | $5.24 | $5.02 | 59,938 | |
| $5.18 | +0.14 | +2.8% | $5.02 | $5.18 | $4.92 | 106,635 | |
| $5.04 | -0.26 | -4.9% | $5.31 | $5.31 | $4.90 | 158,612 | |
| $5.30 | +0.35 | +7.1% | $4.99 | $5.35 | $4.93 | 334,121 | |
| $4.95 | +0.06 | +1.2% | $4.94 | $5.04 | $4.831 | 167,197 | |
| $4.89 | +0.13 | +2.7% | $4.76 | $5.085 | $4.705 | 403,456 | |
| $4.76 | +0.30 | +6.7% | $4.54 | $4.89 | $4.54 | 221,539 | |
| $4.46 | -0.19 | -4.1% | $4.66 | $4.719 | $4.46 | 129,322 | |
| $4.65 | +0.01 | +0.2% | $4.62 | $4.72 | $4.49 | 215,172 | |
| $4.64 | +0.26 | +5.9% | $4.39 | $4.78 | $4.33 | 201,468 | |
| $4.38 | -0.14 | -3.1% | $4.59 | $4.66 | $4.37 | 139,342 | |
| $4.52 | -0.09 | -2.0% | $4.61 | $4.62 | $4.455 | 93,464 | |
| $4.61 | 0.00 | 0.0% | $4.55 | $4.695 | $4.53 | 77,819 | |
| $4.61 | -0.15 | -3.2% | $4.82 | $4.82 | $4.595 | 98,353 | |
| $4.76 | +0.21 | +4.6% | $4.54 | $4.77 | $4.52 | 75,759 | |
| $4.55 | +0.13 | +2.9% | $4.50 | $4.58 | $4.36 | 100,315 | |
| $4.42 | -0.09 | -2.0% | $4.53 | $4.649 | $4.39 | 61,902 | |
| $4.51 | -0.05 | -1.1% | $4.52 | $4.63 | $4.48 | 101,246 | |
| $4.56 | -0.03 | -0.7% | $4.58 | $4.698 | $4.51 | 47,432 | |
| $4.59 | -0.27 | -5.6% | $4.82 | $4.82 | $4.55 | 153,108 | |
| $4.86 | -0.01 | -0.2% | $5.14 | $5.14 | $4.76 | 77,622 | |
| $4.87 | -0.17 | -3.4% | $5.02 | $5.03 | $4.83 | 54,399 | |
| $5.04 | +0.08 | +1.6% | $4.99 | $5.22 | $4.98 | 145,185 | |
| $4.96 | +0.09 | +1.8% | $4.89 | $5.26 | $4.71 | 147,065 | |
| $4.87 | +0.01 | +0.2% | $4.90 | $4.95 | $4.805 | 70,948 | |
| $4.86 | -0.11 | -2.2% | $5.00 | $5.00 | $4.73 | 59,524 | |
| $4.97 | +0.05 | +1.0% | $4.96 | $5.10 | $4.95 | 118,873 | |
| $4.92 | +0.25 | +5.4% | $4.65 | $4.93 | $4.65 | 106,647 | |
| $4.67 | -0.12 | -2.5% | $4.81 | $4.81 | $4.63 | 67,278 | |
| $4.79 | +0.12 | +2.6% | $4.70 | $4.85 | $4.55 | 113,556 | |
| $4.67 | -0.02 | -0.4% | $4.72 | $4.82 | $4.67 | 97,491 | |
| $4.69 | -0.11 | -2.3% | $4.83 | $4.83 | $4.67 | 85,589 | |
| $4.80 | +0.16 | +3.4% | $4.62 | $4.85 | $4.52 | 130,176 | |
| $4.64 | -0.17 | -3.5% | $4.80 | $4.80 | $4.57 | 181,086 | |
| $4.81 | +0.23 | +5.0% | $4.71 | $4.839 | $4.65 | 141,840 | |
| $4.58 | +0.03 | +0.7% | $4.555 | $4.695 | $4.52 | 249,793 | |
| $4.55 | -0.02 | -0.4% | $4.61 | $4.671 | $4.485 | 99,696 | |
| $4.57 | +0.14 | +3.2% | $4.45 | $4.65 | $4.43 | 145,677 | |
| $4.43 | +0.24 | +5.7% | $4.24 | $4.46 | $4.13 | 116,954 |
- Ticker
- NASDAQ:COYA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Coya Therapeutics to Present Neurofilament Light Chain (NfL) Biomarker Stratification Methodology in the ALSTARS Trial to Minimize the Impact of Heterogeneity in ALS Clinical Trials at the 2026 Annual NEALS Meeting
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 25 slides
Latest news
Coya Therapeutics to Present Neurofilament Light Chain (NfL) Biomarker Stratification Methodology in the ALSTARS Trial to Minimize the Impact of Heterogeneity in ALS Clinical Trials at the 2026 Annual NEALS Meeting
Oct 28, 2026
Closed $4.06 (-1.5%) on Oct 28, 2026
Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
Oct 14, 2026
Closed $4.18 (-6.6%) on Oct 14, 2026
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Oct 13, 2026
Closed $4.48 (-7.0%) on Oct 13, 2026
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Oct 5, 2026
Closed $4.85 (+0.8%) on Oct 5, 2026
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
Sep 8, 2026
Closed $4.61 (-3.2%) on Sep 8, 2026
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Aug 11, 2026
Closed $4.80 (+3.4%) on Aug 11, 2026
Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
Jun 18, 2026
Closed $4.92 (-2.2%) on Jun 18, 2026
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
Jun 15, 2026
Closed $4.89 (+3.2%) on Jun 15, 2026
Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
Jun 8, 2026
Closed $4.55 (+2.9%) on Jun 8, 2026
Coya Therapeutics to Present ALSTARS Trial Design at the 5th ALS Drug Development Summit
May 27, 2026
Closed $4.77 (+1.3%) on May 27, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 25 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 25 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 25 slides · August 2026
Investor Presentation (July 2026)
Investor deck · 18 slides · July 2026
Coya Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 104 in all · newest Oct 28, 2026 · oldest 2023
- Decks
- 23 decks · latest October 2026
Where Coya Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:COYA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:COYA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Coya Therapeutics, Inc.